FR2387988A1 - Esters de cefuroxime, leur preparation et leur application therapeutique - Google Patents

Esters de cefuroxime, leur preparation et leur application therapeutique

Info

Publication number
FR2387988A1
FR2387988A1 FR7811514A FR7811514A FR2387988A1 FR 2387988 A1 FR2387988 A1 FR 2387988A1 FR 7811514 A FR7811514 A FR 7811514A FR 7811514 A FR7811514 A FR 7811514A FR 2387988 A1 FR2387988 A1 FR 2387988A1
Authority
FR
France
Prior art keywords
preparation
therapeutic application
cefuroxime
esters
cefuroxime esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7811514A
Other languages
English (en)
French (fr)
Other versions
FR2387988B1 (da
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Glaxo Laboratories Ltd
Original Assignee
Laboratoires Glaxo SA
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo SA, Glaxo Laboratories Ltd filed Critical Laboratoires Glaxo SA
Publication of FR2387988A1 publication Critical patent/FR2387988A1/fr
Application granted granted Critical
Publication of FR2387988B1 publication Critical patent/FR2387988B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00Preparation of esters of carbonic or haloformic acids
    • C07C68/06Preparation of esters of carbonic or haloformic acids from organic carbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00Preparation of esters of carbonic or haloformic acids
    • C07C68/02Preparation of esters of carbonic or haloformic acids from phosgene or haloformates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7811514A 1977-04-19 1978-04-19 Esters de cefuroxime, leur preparation et leur application therapeutique Granted FR2387988A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16202/77A GB1598568A (en) 1977-04-19 1977-04-19 Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid

Publications (2)

Publication Number Publication Date
FR2387988A1 true FR2387988A1 (fr) 1978-11-17
FR2387988B1 FR2387988B1 (da) 1982-06-11

Family

ID=10073017

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7811514A Granted FR2387988A1 (fr) 1977-04-19 1978-04-19 Esters de cefuroxime, leur preparation et leur application therapeutique

Country Status (20)

Country Link
JP (1) JPS53132592A (da)
KR (1) KR840000081B1 (da)
AT (1) AT363183B (da)
AU (1) AU521098B2 (da)
BE (1) BE866093A (da)
CA (1) CA1093068A (da)
CH (1) CH639096A5 (da)
DE (1) DE2816873A1 (da)
DK (1) DK147513C (da)
ES (1) ES468895A1 (da)
FR (1) FR2387988A1 (da)
GB (1) GB1598568A (da)
IE (1) IE46726B1 (da)
IL (1) IL54531A (da)
IT (1) IT1104842B (da)
NL (1) NL7804097A (da)
NZ (1) NZ186998A (da)
SE (1) SE433748B (da)
YU (1) YU90978A (da)
ZA (1) ZA782211B (da)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0061162A2 (en) * 1981-03-23 1982-09-29 Kyoto Yakuhin Kogyo Kabushiki Kaisha Cephalosporin derivatives, pharmaceutical compositions containing the same and production thereof
FR2532933A1 (fr) * 1982-06-29 1984-03-16 Astra Laekemedel Ab Perfectionnements apportes a la preparation d'antibiotiques
US4592872A (en) * 1980-05-14 1986-06-03 Societe Nationale Des Poudres Et Explosifs Process for the synthesis of α-chlorinated chloroformates
US4820857A (en) * 1982-09-20 1989-04-11 Astra Lakemedel Aktiebolag α-bromodiethylcarbonate
US5202454A (en) * 1986-07-11 1993-04-13 Societe Nationale Des Poudres Et Explosifs Process for the manufacture of 1-bromoalkyl hydrocarbyl carbonates

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68992A (en) * 1982-06-29 1991-06-10 Astra Laekemedel Ab Alpha-bromo diethyl carbonate and process for the preparation of ethoxycarbonyloxy esters of penicillanic acids
IT1190897B (it) * 1982-06-29 1988-02-24 Opos Biochimica Srl Procedimento per la preparazione dell'estere 1-etossicarbonilossietilico dell'acido 6-(d(-)-alfa aminoalfa fenilacetamido)-penicillanico
GB2123821B (en) * 1982-06-29 1987-04-23 Astra Laekemedel Ab At-halogeno diethyl carbonates and their use in the preparation of antibiotics
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
IL67623A (en) * 1983-01-05 1984-09-30 Teva Pharma 1'-ethoxycarbonyloxyethyl ester of valproic acid,its preparation and pharmaceutical compositions containing it
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
FR2551058B1 (fr) * 1983-08-26 1986-09-26 Poudres & Explosifs Ste Nale Procede de preparation de chloroformiates a-chlores
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
US4612143A (en) * 1984-09-17 1986-09-16 Societe Nationale Des Poudres Et Explosifs Process for the preparation of fluoroformates
KR100342944B1 (ko) 1999-11-08 2002-07-02 민경윤 고순도 세프포독심 프록세틸의 제조방법
GB0301938D0 (en) * 2003-01-28 2003-02-26 Biochemie Gmbh Organic compounds

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2241318A2 (da) * 1973-08-21 1975-03-21 Glaxo Lab Ltd
FR2340951A1 (fr) * 1976-02-16 1977-09-09 Glaxo Lab Ltd Derives de cefuroxime, leur procede de preparation et leur application en therapeutique
FR2340950A1 (fr) * 1976-02-16 1977-09-09 Glaxo Lab Ltd Esters du cefuroxime, leur procede de preparation et leur application en therapeutique

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2241318A2 (da) * 1973-08-21 1975-03-21 Glaxo Lab Ltd
GB1453049A (en) * 1973-08-21 1976-10-20 Glaxo Lab Ltd Cephalosporing antibiotics
FR2340951A1 (fr) * 1976-02-16 1977-09-09 Glaxo Lab Ltd Derives de cefuroxime, leur procede de preparation et leur application en therapeutique
FR2340950A1 (fr) * 1976-02-16 1977-09-09 Glaxo Lab Ltd Esters du cefuroxime, leur procede de preparation et leur application en therapeutique

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4592872A (en) * 1980-05-14 1986-06-03 Societe Nationale Des Poudres Et Explosifs Process for the synthesis of α-chlorinated chloroformates
US4592874A (en) * 1980-05-14 1986-06-03 Societe Nationale Des Poudres Et Explosifs Process for the synthesis of alpha-chlorinated chloroformates
EP0061162A2 (en) * 1981-03-23 1982-09-29 Kyoto Yakuhin Kogyo Kabushiki Kaisha Cephalosporin derivatives, pharmaceutical compositions containing the same and production thereof
EP0061162A3 (en) * 1981-03-23 1983-06-08 Kyoto Yakuhin Kogyo Kabushiki Kaisha Cephalosporin derivatives, pharmaceutical compositions containing the same and production thereof
FR2532933A1 (fr) * 1982-06-29 1984-03-16 Astra Laekemedel Ab Perfectionnements apportes a la preparation d'antibiotiques
US4820857A (en) * 1982-09-20 1989-04-11 Astra Lakemedel Aktiebolag α-bromodiethylcarbonate
US5202454A (en) * 1986-07-11 1993-04-13 Societe Nationale Des Poudres Et Explosifs Process for the manufacture of 1-bromoalkyl hydrocarbyl carbonates

Also Published As

Publication number Publication date
SE7804400L (sv) 1978-10-20
ATA274878A (de) 1980-12-15
ES468895A1 (es) 1978-12-01
NL7804097A (nl) 1978-10-23
ZA782211B (en) 1979-04-25
JPS53132592A (en) 1978-11-18
IL54531A (en) 1981-07-31
KR840000081B1 (ko) 1984-02-08
GB1598568A (en) 1981-09-23
DK147513C (da) 1985-03-18
IE780760L (en) 1978-10-19
CH639096A5 (en) 1983-10-31
DK168778A (da) 1978-10-20
BE866093A (fr) 1978-10-18
DK147513B (da) 1984-09-10
KR830000246A (ko) 1983-03-30
NZ186998A (en) 1981-05-01
IT7848941A0 (it) 1978-04-18
DE2816873A1 (de) 1978-11-02
AU3518778A (en) 1979-10-25
AU521098B2 (en) 1982-03-18
SE433748B (sv) 1984-06-12
IT1104842B (it) 1985-10-28
IE46726B1 (en) 1983-09-07
CA1093068A (en) 1981-01-06
AT363183B (de) 1981-07-10
FR2387988B1 (da) 1982-06-11
YU90978A (en) 1983-01-21
IL54531A0 (en) 1978-07-31

Similar Documents

Publication Publication Date Title
FR2392016A1 (fr) Derives de mevalonolactone, leur procede de preparation et leur application therapeutique
FR2385722A1 (fr) Nouveaux derives de cephalosporine, leur procede de preparation et leur application en therapeutique
FR2398748A1 (fr) Nouveaux derives d'imidazoquinazoline, leur preparation et leur application en tant que medicaments
FR2387954A1 (fr) Derives de mercaptoalkylsulfonylproline et composes apparentes, et leur utilisation comme medicaments
FR2417510A1 (fr) 9-amino- et imino-dibenzopyrannes et leur utilisation therapeutique
FR2387988A1 (fr) Esters de cefuroxime, leur preparation et leur application therapeutique
FR2364219A1 (fr) Derives de thiazolidine, leur procede de preparation et leur application en therapeutique
FR2389629A1 (da)
FR2389605A1 (da)
FR2383165A1 (fr) Nouveaux derives d'acides phenoxy-a-phenoxy-alcanecarboxyliques, leur preparation et leur application comme herbicides
FR2384745A1 (fr) Derives de la somatostatine et leur preparation
FR2398058A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2387214A1 (fr) Derives du p-aminomethyl benzene-sulfonamide, leur procede de preparation et leur application therapeutique
FR2389597A1 (da)
FR2368489A1 (fr) Derives de la clavuline, leur procede de preparation et leur application en therapeutique
FR2404001A1 (fr) Derives d'oxazolidone-2 utiles comme medicaments et procedes pour leur preparation
FR2399465A1 (fr) Nouveaux complexes chromiferes 1 : 2, leur preparation et leur application comme colorants
FR2399406A1 (fr) Derives de perhydronaphtalenepentol et leur utilisation therapeutique
FR2359116A1 (fr) N-alkyldiphenylamines
FR2389615A1 (da)
FR2446282A1 (fr) Phenylthiophenylpiperidines, leur preparation et leurs applications therapeutiques
FR2378015A1 (fr) Nouveaux derives de la benzo(f)isoquinoleine, leur preparation et leur application comme medicaments
FR2389624A1 (da)
FR2392011A1 (fr) Nouveaux derives de la 5-phenyl-1h-3-benzazepine, leur preparation et leur utilisation comme medicaments
FR2376155A1 (fr) Thiophosphorylguanidines anti-parasitaires et leur preparation

Legal Events

Date Code Title Description
ST Notification of lapse